Elementis PLC

Latest Results (06.03.2026):

Elementis PLC — results for the first half of 2025 (six months ended 30 June 2025, covering Q2 2025): the company reported a resilient set of results from continuing operations with revenue broadly stable at $308m, adjusted operating profit up to $65m and improved margins, a sharply reduced net debt position and completion of the Talc divestment. Management also launched the new "Elevate Elementis" strategy with medium‑term growth and return targets.

Headline financials

Revenue was $307.9m (down ~1% constant currency). Adjusted operating profit rose to $65.3m (+7% cc) and adjusted operating margin improved to c.21% (21.2%). Statutory operating profit from continuing operations was $57.0m.

Profitability and EPS

Adjusted diluted EPS increased to 6.8 cents (up ~19% year‑on‑year). Reported profit from continuing operations was $35.1m; adjusted measures benefited from pricing, cost savings and lower net finance costs.

Segment performance

Personal Care grew (sales $116.4m, +2% cc) with record margins ~34% driven by Cosmetics and AP Actives innovations. Coatings sales were weaker ($191.5m, down ~3–4% cc) but margins remained resilient at ~18% despite softer market demand.

Balance sheet, cash and buyback

Net debt fell to $125m (down ~36% since 31 Dec 2024) and net debt/EBITDA was 0.9x. Free cash flow was positive and the company initiated a $50m share buyback funded from Talc sale proceeds (buyback in progress).

Talc divestment & discontinued operations

The Talc business was sold (completed 27 May 2025); enterprise value and net proceeds were reported and net cash proceeds were returned in part to shareholders. The loss from discontinued operations was reported as $100.2m for the period.

Dividend

The Board declared an interim dividend of 1.3 cents per share (up from 1.1 cents), in line with the progressive dividend policy; payment is scheduled in pounds sterling.

Strategy and medium‑term targets

“Elevate Elementis” was launched to accelerate growth and returns: medium‑term ambitions include mid‑single digit revenue growth, adjusted operating margin 23%+, >90% three‑year operating cash conversion and ROCE (ex‑goodwill) >30%; incremental $10m savings planned by 2026 plus higher R&D intensity.

Outlook

Management expects full‑year adjusted operating profit to be in line with market consensus (~$126m mean) assuming no material change in demand; they note ongoing operational actions (OTIF, debottlenecking) to drive growth and service improvements.